194 related articles for article (PubMed ID: 37781371)
21. Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies.
Rouha H; Weber S; Janesch P; Maierhofer B; Gross K; Dolezilkova I; Mirkina I; Visram ZC; Malafa S; Stulik L; Badarau A; Nagy E
Virulence; 2018 Jan; 9(1):231-247. PubMed ID: 29099326
[TBL] [Abstract][Full Text] [Related]
22. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.
Karauzum H; Adhikari RP; Sarwar J; Devi VS; Abaandou L; Haudenschild C; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Warfield KL; Shulenin S; Aman MJ
PLoS One; 2013; 8(6):e65384. PubMed ID: 23762356
[TBL] [Abstract][Full Text] [Related]
23. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
[TBL] [Abstract][Full Text] [Related]
24. Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins.
Yanai M; Rocha MA; Matolek AZ; Chintalacharuvu A; Taira Y; Chintalacharuvu K; Beenhouwer DO
PLoS One; 2014; 9(2):e89308. PubMed ID: 24586678
[TBL] [Abstract][Full Text] [Related]
25. α-hemolysin of Staphylococcus aureus impairs thrombus formation.
Jahn K; Handtke S; Palankar R; Kohler TP; Wesche J; Wolff M; Bayer J; Wolz C; Greinacher A; Hammerschmidt S
J Thromb Haemost; 2022 Jun; 20(6):1464-1475. PubMed ID: 35303391
[TBL] [Abstract][Full Text] [Related]
26. Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia.
Adhikari RP; Karauzum H; Sarwar J; Abaandou L; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Devi VS; Shulenin S; Warfield KL; Aman MJ
PLoS One; 2012; 7(6):e38567. PubMed ID: 22701668
[TBL] [Abstract][Full Text] [Related]
27. Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model.
Lipinska U; Hermans K; Meulemans L; Dumitrescu O; Badiou C; Duchateau L; Haesebrouck F; Etienne J; Lina G
PLoS One; 2011; 6(8):e22864. PubMed ID: 21850240
[TBL] [Abstract][Full Text] [Related]
28. IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by
Karauzum H; Venkatasubramaniam A; Adhikari RP; Kort T; Holtsberg FW; Mukherjee I; Mednikov M; Ortines R; Nguyen NTQ; Doan TMN; Diep BA; Lee JC; Aman MJ
Front Immunol; 2021; 12():624310. PubMed ID: 33777005
[No Abstract] [Full Text] [Related]
29. Immunogenicity of toxins during Staphylococcus aureus infection.
Verkaik NJ; Dauwalder O; Antri K; Boubekri I; de Vogel CP; Badiou C; Bes M; Vandenesch F; Tazir M; Hooijkaas H; Verbrugh HA; van Belkum A; Etienne J; Lina G; Ramdani-Bouguessa N; van Wamel WJ
Clin Infect Dis; 2010 Jan; 50(1):61-8. PubMed ID: 19947854
[TBL] [Abstract][Full Text] [Related]
30. IVIG-mediated protection against necrotizing pneumonia caused by MRSA.
Diep BA; Le VT; Badiou C; Le HN; Pinheiro MG; Duong AH; Wang X; Dip EC; Aguiar-Alves F; Basuino L; Marbach H; Mai TT; Sarda MN; Kajikawa O; Matute-Bello G; Tkaczyk C; Rasigade JP; Sellman BR; Chambers HF; Lina G
Sci Transl Med; 2016 Sep; 8(357):357ra124. PubMed ID: 27655850
[TBL] [Abstract][Full Text] [Related]
31. Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia.
Tam K; Lacey KA; Devlin JC; Coffre M; Sommerfield A; Chan R; O'Malley A; Koralov SB; Loke P; Torres VJ
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32602902
[TBL] [Abstract][Full Text] [Related]
32. Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin.
Scherr TD; Hanke ML; Huang O; James DB; Horswill AR; Bayles KW; Fey PD; Torres VJ; Kielian T
mBio; 2015 Aug; 6(4):. PubMed ID: 26307164
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus.
Aguilar JL; Varshney AK; Pechuan X; Dutta K; Nosanchuk JD; Fries BC
Virulence; 2017 Aug; 8(6):741-750. PubMed ID: 27715466
[TBL] [Abstract][Full Text] [Related]
34. Rational Design of Toxoid Vaccine Candidates for
Kailasan S; Kort T; Mukherjee I; Liao GC; Kanipakala T; Williston N; Ganjbaksh N; Venkatasubramaniam A; Holtsberg FW; Karauzum H; Adhikari RP; Aman MJ
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31207937
[No Abstract] [Full Text] [Related]
35. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
[TBL] [Abstract][Full Text] [Related]
36. Panton-Valentine leukocidin-secreting Staphylococcus aureus causing severe musculoskeletal sepsis in children. A new threat.
Mitchell PD; Hunt DM; Lyall H; Nolan M; Tudor-Williams G
J Bone Joint Surg Br; 2007 Sep; 89(9):1239-42. PubMed ID: 17905965
[TBL] [Abstract][Full Text] [Related]
37. Association of recurrent furunculosis with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus.
Masiuk H; Kopron K; Grumann D; Goerke C; Kolata J; Jursa-Kulesza J; Giedrys-Kalemba S; Bröker BM; Holtfreter S
J Clin Microbiol; 2010 May; 48(5):1527-35. PubMed ID: 20200289
[TBL] [Abstract][Full Text] [Related]
38. Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.
Le VT; Tkaczyk C; Chau S; Rao RL; Dip EC; Pereira-Franchi EP; Cheng L; Lee S; Koelkebeck H; Hilliard JJ; Yu XQ; Datta V; Nguyen V; Weiss W; Prokai L; O'Day T; Stover CK; Sellman BR; Diep BA
Antimicrob Agents Chemother; 2016 Oct; 60(10):5640-8. PubMed ID: 27401576
[TBL] [Abstract][Full Text] [Related]
39. Necrotizing pneumonia due to clonally diverse Staphylococcus aureus strains producing Panton-Valentine leukocidin: the Czech experience.
Rájová J; Pantůček R; Petráš P; Varbanovová I; Mašlaňová I; Beneš J
Epidemiol Infect; 2016 Feb; 144(3):507-15. PubMed ID: 26201459
[TBL] [Abstract][Full Text] [Related]
40. Deciphering the Pathological Role of Staphylococcal α-Toxin and Panton-Valentine Leukocidin Using a Novel
Olaniyi RO; Pancotto L; Grimaldi L; Bagnoli F
Front Immunol; 2018; 9():951. PubMed ID: 29867940
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
